# Real-world Study on Adjuvant Octreotide Therapy in pNETs

> **NCT06080204** · NA · COMPLETED · sponsor: **Changhai Hospital** · enrollment: 411 (actual)

## Conditions studied

- Pancreatic Neuroendocrine Tumor G2

## Interventions

- **DRUG:** Octreotide LAR

## Key facts

- **NCT ID:** NCT06080204
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 411 (ACTUAL)
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06080204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06080204, "Real-world Study on Adjuvant Octreotide Therapy in pNETs". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06080204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*